Navigation Links
Actos Bladder Cancer Lawsuits Move Forward, with Issuance of New Order in Federal Actos Litigation, Bernstein Liebhard LLP Reports
Date:9/8/2013

New York, New York (PRWEB) September 08, 2013

Actos lawsuits(http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) filed on behalf of people who allegedly developed bladder cancer due to prolonged use of the Type 2 diabetes drug continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to an Order issued by the Court on August 26th, the parties have been directed to meet and confer, in person, prior to the filing of certain motions, in order to attempt to resolve issues before they are brought to the attention of the Court. (In re: Actos Product Liability Litigation, MDL No. 2299)

“More than than two years after U.S. regulators warned of the potential for Actos bladder cancer, our Firm continues to hear from long-term users of this drug who developed the disease. We are pleased to see federal Actos lawsuits moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free lawsuit evaluations to long-term Actos users who were diagnosed with bladder cancer, allegedly due to their use of the Type 2 diabetes drug.

Actos Bladder Cancer
The litigation surrounding Actos has been growing since June 2011, when the U.S. Food & Drug Administration (FDA) warned that use of Actos for one year or more had been linked to the development of bladder cancer. Court documents indicate that more than 2,500 Actos lawsuits have been filed in the federal multidistrict litigation underway in Louisiana. All of the claims pending in the proceeding allege that long-term users of Actos are a
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
2. Actos Lawsuit News: Bernstein Liebhard LLP Notes Start of Second Actos Bladder Cancer Trial in Maryland State Court
3. Actos Bladder Cancer Lawsuits Help: Resource4thePeople Reports Number of Consolidated Federal Cases Climbs to over 2,500
4. Actos Lawsuits Move Forward Following Latest Status Conference in Federal Actos Bladder Cancer Litigation
5. Oregon Man Developed Bladder Cancer Brought on by Years of Ingesting Diabetes Drug Actos, Alleges Lawsuit Filed by Parker Waichman LLP
6. Florida Woman Developed Bladder Cancer After Taking Actos to Treat her Type II Diabetes, Alleges Lawsuit Filed by Parker Waichman LLP
7. Years of Ingesting Diabetes Drug Actos Caused Florida Man to Develop Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP
8. Actos Lawsuits Alleging Bladder Cancer Update: Resource4thePeople Reports Judge Continues to Move Multidistrict Litigation Forward
9. Organic Valley Presents Lactose Free Whole Milk and Lactose Free Half & Half
10. Actos Lawsuit – Status Conference Convened in Federal Actos Bladder Cancer Multidistrict Litigation, Bernstein Liebhard LLP Reports
11. Actos Lawsuit News: More Than a Dozen Lawsuits Filed in West Virginia, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... with nasal septum cells. Researchers at the University and ... from the nasal septum are able to adapt to ... repair articular cartilage defects. The nasal cartilage cells, ability ... associated with the expression of so-called HOX genes. The ... the research results together with the report of the ...
(Date:8/28/2014)... working out how to safely increase the radiotherapy dose ... local control and survival. , Standard treatment for locally ... radiotherapy and chemotherapy. Traditionally this is planned in a ... be enough to stop tumour growth. , The potential ... varies between patients and depends on the size and ...
(Date:8/28/2014)... 28, 2014 Parker Waichman LLP, a ... years fighting to ensure that the heroes of 9/11 ... coverage to WTC victims who developed 9/11-related cancer was ... Accountability Office (GAO). According to a statement issued by ... report is entitled “World Trade Center Health Program: Approach ...
(Date:8/28/2014)... By Steven Reinberg ... -- Treating pre-cancerous skin spots with a type of light ... freezing the lesions with liquid nitrogen, a new study suggests. ... on the scalp and face of people with fair complexions ... review of prior research found that people who underwent the ...
(Date:8/28/2014)... Alexandria, VA (PRWEB) August 28, 2014 ... Foundation) will interview Stephen Isaacs, the chairperson, president and ... the Foundation’s Meet the Mesothelioma Experts live ... Foundation’s executive director and mesothelioma expert nurse practitioner, ... the interview will be Aduro BioTech’s experimental therapy for ...
Breaking Medicine News(10 mins):Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3
... 22 Although Attention Deficit ... as only affecting children, for nearly 9 million adults ... reality. According to the National Institutes of Mental Health, ... to a job, remembering or keeping appointments and being ...
... Earn Decision Resources, Clinical Gold Standard Status for ... Report from Decision ResourcesWALTHAM, Mass., April 22 ... and advisory firms for pharmaceutical and healthcare issues, ... on overall survival as the attribute that most ...
... -- Drug side effects are a major problem,for the ... can warrant,drug withdrawal. Unfortunately, these problems often emerge only ... millions of patients. , Identifying ... the,clinic is a major focus of ReproCELL. Current cardiotoxicity ...
... New Plan Designs Help Employers and Their Employees Manage ... Life Insurance Company of America (Guardian), one of the ... employee and voluntary benefits for small and mid-sized companies, ... lineup that will broaden access to more affordable dental ...
... April 22 Celator Pharmaceuticals today ... CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in consolidation treatment for ... in combination with biological agents for the treatment ... Annual Meeting of the American Association for Cancer ...
... 22 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) ... Sanja Pekovic provided updates from a recent medical ... Gesellschaft - Nederlandse Anatomen Vereniging, Antwerpen, 27-30 March ... of recent positive testing being conducted related to ...
Cached Medicine News:Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 2Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 3Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 4Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 5Health News:Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer 2Health News:Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer 3Health News:New Stem Cell Technology to Improve Drug Safety 2Health News:Guardian Adds New Cost-Conscious Options to Group Dental Lineup 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 3Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 2Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 3
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate Ebola ... Gambia and Mali ... trials of potential vaccines aimed at preventing the disease that has ... West Africa . Human trials of this ... (NIH) and GlaxoSmithKline, are to be accelerated with funding from an ...
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, ... leader in noninvasive medical monitoring, today announced that the ... Model 3231 OEM/eHealth finger pulse oximeter for use in ... pulse oximeter plugs into a telemedicine hub or kiosk ... pulse rate in pediatric to adult patients. The Model ...
(Date:8/28/2014)... , Aug. 28, 2014   Edison ... today announced a worldwide search for product ideas ... senior population.  Promising ideas uncovered through the 6-month ... leading medical device manufacturers and healthcare retailers with ... the lives of individuals age 65 and older. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced ... ® (topiramate) 100mg Tablets.  These two lots ... in the U.S. and Puerto Rico.  While the ... , the company believes there are fewer than ...
... (Nasdaq: CDXS ) today announced the company will ... 2011 at 4:30 p.m. Eastern Time to discuss its first ... 2011.  The call and webcast will follow the release of ... of the call will be available approximately one hour after ...
Cached Medicine Technology:Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 2Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 3Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 4Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: